drugset / Trial / NCT01620788

Comparison of Losartan Associated With Indapamide Versus Hyzaar® in the Hypertension Treatment

NCT01620788

Phase 3 Suspended 636 enrolled EMS
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate the clinical efficacy of indapamide 1.5mg / losartan 50mg and indapamide 1.5mg / losartan 100mg on reduction of blood pressure.

Timeline

Start
2019-11-27
Primary completion
2023-07
Completion
2023-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Hydrochlorothiazide Unknown Oral
Subject Indapamide Small molecule 1.5 mg Oral
Subject Losartan Other / unclassified 50 mg Oral
Subject Losartan Other / unclassified 100 mg Oral

Indications